# ECB Bancorp, Inc.: financial statements, quarterly

ECBK · Nasdaq · CIK 1914605 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ecbk.md) · [Financials](/companies/ecbk/financials.md) · [Filings](/companies/ecbk/filings.md) · [Insiders](/companies/ecbk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ecbk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.1](/filings/0001437749-26-015758.md) | [0.2](/filings/0001437749-26-026449.md) | not reported | not reported | [0.2](/filings/0001437749-26-015758.md) | [0.2](/filings/0001437749-26-026449.md) |
| Interest expense | $m | [8.1](/filings/0000950170-24-123717.md) | [9.0 d](/filings/0000950170-24-038505.md) | [9.8](/filings/0000950170-24-057540.md) | [10.4](/filings/0000950170-24-094509.md) | [10.9](/filings/0000950170-24-123717.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [0.4](/filings/0000950170-24-123717.md) | [0.3 d](/filings/0000950170-25-045444.md) | [0.2](/filings/0000950170-25-067593.md) | [0.3](/filings/0001437749-25-025715.md) | [0.4](/filings/0001437749-25-033851.md) | [0.5 d](/filings/0001437749-26-009778.md) | [0.4](/filings/0001437749-26-015758.md) | [0.5](/filings/0001437749-26-026449.md) | [0.8](/filings/0001437749-25-033851.md) | [0.9 d](/filings/0001437749-26-009778.md) | [1.1](/filings/0001437749-26-015758.md) | [1.2](/filings/0001437749-26-026449.md) |
| Net income | $m | [1.3](/filings/0000950170-24-123717.md) | [0.8 d](/filings/0000950170-25-045444.md) | [0.6](/filings/0000950170-25-067593.md) | [0.8](/filings/0001437749-25-025715.md) | [1.1](/filings/0001437749-25-033851.md) | [1.4 d](/filings/0001437749-26-009778.md) | [1.3](/filings/0001437749-26-015758.md) | [1.4](/filings/0001437749-26-026449.md) | [2.4](/filings/0001437749-25-033851.md) | [2.6 d](/filings/0001437749-26-009778.md) | [3.1](/filings/0001437749-26-015758.md) | [3.3](/filings/0001437749-26-026449.md) |
| Diluted EPS | $ per share | [0.16](/filings/0000950170-24-123717.md) | not reported | [0.07](/filings/0000950170-25-067593.md) | [0.09](/filings/0001437749-25-025715.md) | [0.14](/filings/0001437749-25-033851.md) | not reported | [0.16](/filings/0001437749-26-015758.md) | [0.17](/filings/0001437749-26-026449.md) | [0.29](/filings/0001437749-25-033851.md) | not reported | [0.38](/filings/0001437749-26-015758.md) | [0.39](/filings/0001437749-26-026449.md) |
| Basic EPS | $ per share | [0.16](/filings/0000950170-24-123717.md) | not reported | [0.07](/filings/0000950170-25-067593.md) | [0.10](/filings/0001437749-25-025715.md) | [0.14](/filings/0001437749-25-033851.md) | not reported | [0.16](/filings/0001437749-26-015758.md) | [0.18](/filings/0001437749-26-026449.md) | [0.30](/filings/0001437749-25-033851.md) | not reported | [0.39](/filings/0001437749-26-015758.md) | [0.41](/filings/0001437749-26-026449.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [1,214](/filings/0000950170-23-061979.md) | [1,280](/filings/0000950170-25-045444.md) | [1,303](/filings/0000950170-24-057540.md) | [1,336](/filings/0000950170-24-094509.md) | [1,358](/filings/0000950170-24-123717.md) | [1,418](/filings/0001437749-26-009778.md) | [1,452](/filings/0000950170-25-067593.md) | [1,515](/filings/0001437749-25-025715.md) | [1,553](/filings/0001437749-25-033851.md) | [1,606](/filings/0001437749-26-026449.md) | [1,650](/filings/0001437749-26-015758.md) | [1,672](/filings/0001437749-26-026449.md) |
| Total liabilities | $m | [1,048](/filings/0000950170-23-061979.md) | [1,115](/filings/0000950170-25-045444.md) | [1,138](/filings/0000950170-24-057540.md) | [1,169](/filings/0000950170-24-094509.md) | [1,192](/filings/0000950170-24-123717.md) | [1,250](/filings/0001437749-26-009778.md) | [1,284](/filings/0000950170-25-067593.md) | [1,347](/filings/0001437749-25-025715.md) | [1,383](/filings/0001437749-25-033851.md) | [1,434](/filings/0001437749-26-026449.md) | [1,474](/filings/0001437749-26-015758.md) | [1,492](/filings/0001437749-26-026449.md) |
| Shareholders' equity | $m | [166](/filings/0000950170-24-123717.md) | [165](/filings/0001437749-26-009778.md) | [166](/filings/0001437749-25-025715.md) | [166](/filings/0001437749-25-033851.md) | [166](/filings/0001437749-25-033851.md) | [168](/filings/0001437749-26-026449.md) | [169](/filings/0001437749-26-026449.md) | [168](/filings/0001437749-26-026449.md) | [169](/filings/0001437749-25-033851.md) | [172](/filings/0001437749-26-026449.md) | [176](/filings/0001437749-26-026449.md) | [180](/filings/0001437749-26-026449.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [0.4 d](/filings/0000950170-24-123717.md) | [2.6 d](/filings/0000950170-25-045444.md) | [(0.4)](/filings/0000950170-25-067593.md) | [1.4 d](/filings/0001437749-25-025715.md) | [0.9 d](/filings/0001437749-25-033851.md) | [4.4 d](/filings/0001437749-26-009778.md) | [(0.6)](/filings/0001437749-26-015758.md) | [1.9 d](/filings/0001437749-26-026449.md) | [4.0 d](/filings/0001437749-25-033851.md) | [3.9 d](/filings/0001437749-26-009778.md) | [2.8](/filings/0001437749-26-015758.md) | [12.0 d](/filings/0001437749-26-026449.md) |
| Capital expenditure | $m | [0.1 d](/filings/0000950170-24-123717.md) | [0.1 d](/filings/0000950170-25-045444.md) | [0.0](/filings/0000950170-25-067593.md) | [0.0 d](/filings/0001437749-25-025715.md) | [0.0 d](/filings/0001437749-25-033851.md) | [0.0 d](/filings/0001437749-26-009778.md) | [0.0](/filings/0001437749-26-015758.md) | [0.1 d](/filings/0001437749-26-026449.md) | [0.1 d](/filings/0001437749-25-033851.md) | [0.1 d](/filings/0001437749-26-009778.md) | [0.0](/filings/0001437749-26-015758.md) | [0.2 d](/filings/0001437749-26-026449.md) |
| Share repurchases | $m | not reported | [1.6 d](/filings/0000950170-25-045444.md) | [0.6](/filings/0000950170-25-067593.md) | [0.5 d](/filings/0001437749-25-025715.md) | [0.7 d](/filings/0001437749-25-033851.md) | [0.9 d](/filings/0001437749-26-009778.md) | [0.7](/filings/0001437749-26-015758.md) | [1.5 d](/filings/0001437749-26-026449.md) | [2.0 d](/filings/0001437749-25-033851.md) | [0.5 d](/filings/0001437749-26-009778.md) | [0.4](/filings/0001437749-26-015758.md) | [0.7 d](/filings/0001437749-26-026449.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [8,446](/filings/0000950170-23-061979.md) | [8,481](/filings/0000950170-24-057540.md) | [8,490](/filings/0000950170-24-094509.md) | [8,487](/filings/0000950170-24-123717.md) | [8,375](/filings/0000950170-25-067593.md) | [8,343](/filings/0001437749-25-025715.md) | [8,344](/filings/0001437749-25-033851.md) | [8,344](/filings/0001437749-26-015758.md) | [8,370](/filings/0001437749-26-026449.md) | [8,275](/filings/0001437749-25-033851.md) | [8,300](/filings/0001437749-26-015758.md) | [8,337](/filings/0001437749-26-026449.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 8,737,702 at 2026-08-06, from the cover of the [10-Q filed 2026-08-07](/filings/0001437749-26-026449.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.